Blood Pressure and Breast Cancer Survival in Black Women

Black women in the U. S. face higher death rates from breast cancer and also have common high blood pressure. A study followed 2, 474 Black women who were diagnosed with invasive breast cancer to see how their blood pressure status and use of heart‑pressure drugs affected survival. Every two years the researchers checked whether participants had hypertension and if they were taking medications for it. Cancer outcomes were confirmed through medical records and cancer registries. The team used statistical models that considered treatment, lifestyle, and other health factors to calculate the risk of dying from breast cancer. For all participants combined, having untreated high blood pressure did not significantly change the risk of breast cancer death compared to those with normal pressure (hazard ratio ~1. 17). However, when hypertension was treated, the risk dropped slightly to about 0. 81, though this finding was not statistically firm.When the researchers looked at hormone‑receptor positive (ER+) tumors, they found a striking pattern: treated hypertension was linked to almost half the risk of cancer death (HR ~0. 53), while untreated high blood pressure showed no clear effect (HR ~0. 96). For hormone‑receptor negative (ER–) tumors, the story was different. Untreated high blood pressure doubled the risk of death (HR ~2. 19), but treated hypertension did not show a clear protective benefit (HR ~1. 32). These results suggest that managing high blood pressure may help Black breast cancer patients survive longer, possibly because regular medication use keeps them more connected to healthcare or because some blood‑pressure drugs may directly inhibit tumor growth. However, the study cannot prove cause and effect; controlled trials are needed to confirm these observations and guide best practices for heart‑health care in cancer patients.